Overexpression of multidrug resistance-associated protein 2 in the brain of pentylenetetrazole-kindled rats

Neuroscience

Volumn 227, Issue , 2012, Pages 283-292

  Yao, D ^a,b   Liu, L ^a   Jin, S ^a   Li, J ^a   Liu, X D ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Antiepileptic effect; Blood brain barrier; Multidrug resistance associated protein 2; Pharmacoresistant epilepsy; Phenytoin

Indexed keywords

BROMSULFOPHTHALEIN; MULTIDRUG RESISTANCE PROTEIN 2; PENTETRAZOLE; PHENYTOIN; PROBENECID;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; HIPPOCAMPUS; KINDLING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RAT; UPREGULATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; BRAIN; CHROMATOGRAPHY, LIQUID; COLORING AGENTS; CONVULSANTS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EPILEPSY; KINDLING, NEUROLOGIC; MALE; MASS SPECTROMETRY; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PENTYLENETETRAZOLE; PHENYTOIN; RATS; RATS, SPRAGUE-DAWLEY; SULFOBROMOPHTHALEIN; TIME FACTORS; UP-REGULATION;

EID: 84868333737     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.10.006     Document Type: Article

References (38)

1. Aronica E., Gorter J.A., Ramkema M., Redeker S., Özbas-Gerçeker F., Van Vliet E.A., Scheffer G.L., Scheper R.J., Van Der Valk P., Baayen J.C. Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia 2004, 45:441-451.
2. Babaei A., Eslamai M. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients. Int J Clin Pharmacol Ther 2007, 45:121-125.
3. Baltes S., Gastens A.M., Fedrowitz M., Potschka H., Kaever V., Löscher W. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology 2007, 52:333-346.
4. Bethmann K., Brandt C., Löscher W. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy. Epilepsia 2007, 48:816-826.
5. Cockerell O., Sander J., Hart Y., Shorvon S., Johnson A. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995, 346:140-144.
6. De Sarro A., Naccari F., De Sarro G. Enhanced susceptibility of pentylenetetrazole kindled mice to quinolone effects. Int J Antimicrob Agents 1999, 12:239-244.
7. Dombrowski S.M., Desai S.Y., Marroni M., Cucullo L., Goodrich K., Bingaman W., Mayberg M.R., Bengez L., Janigro D. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 2001, 42:1501-1506.
8. Fukami M., Tanka A., Takikawa H. Effect of penicillin G on the biliary excretion of cholephilic compounds in rats. J Hepatobiliary Pancreat Sci 2011, 1-5.
9. Guerrini R., Belmonte A., Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998, 39:S2-S10.
10. Hayeshi R., Hilgendorf C., Artursson P., Augustijns P., Brodin B., Dehertogh P., Fisher K., Fossati L., Hovenkamp E., Korjamo T. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. Eur J Pharm Sci 2008, 35:383-396.
11. Hoffmann K., Gastens A.M., Volk H.A., Löscher W. Expression of the multidrug transporter MRP2 in the blood-brain barrier after pilocarpine-induced seizures in rats. Epilepsy Res 2006, 69:1-14.
12. Jing X., Liu X., Wen T., Xie S., Yao D., Wang G., Xie L. Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats. Br J Pharmacol 2010, 159:1511-1522.
13. Jobst B.C., Holmes G.L. Prescribing antiepileptic drugs: should patients be switched on the basis of cost?. CNS Drugs 2004, 18:617-628.
14. Kim W.-J., Lee J.H., Yi J., Cho Y.-J., Heo K., Lee S.H., Kim S.W., Kim M.-K., Kim K.H., In Lee B., Lee M.G. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet Genomics 2010, 20:249-256.
15. Kubota H., Ishihara H., Langmann T., Schmitz G., Stieger B., Wieser H.-G., Yonekawa Y., Frei K. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Epilepsy Res 2006, 68:213-228.
16. Kuteykin-Teplyakov K., Brandt C., Hoffmann K., Löscher W. Complex time-dependent alterations in the brain expression of different drug efflux transporter genes after status epilepticus. Epilepsia 2009, 50:887-897.
17. Löscher W., Cramer S., Ebert U. Limbic epileptogenesis alters the anticonvulsant efficacy of phenytoin in Sprague-Dawley rats. Epilepsy Res 1998, 31:175-186.
18. Löscher W., Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 2002, 301:7-14.
19. Lazarowski A., Czornyj L., Lubienieki F., Girardi E., Vazquez S., D'Giano C. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy. Epilepsia 2007, 48:140-149.
20. Leite J.P., Cavalheiro E.A. Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res 1995, 20:93-104.
21. Li H., Jin H.-E., Kim W., Han Y.-H., Kim D.-D., Chung S.-J., Shim C.-K. Involvement of P-glycoprotein, multidrug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells. Pharm Res 2008, 25:2601-2612.
22. Liu X., Yang Z., Yang J., Yang H. Increased P-glycoprotein expression and decreased phenobarbital distribution in the brain of pentylenetetrazole-kindled rats. Neuropharmacology 2007, 53:657-663.
23. Luna-Tortós C., Fedrowitz M., Löscher W. Several major antiepileptic drugs are substrates for human P-glycoprotein. Neuropharmacology 2008, 55:1364-1375.
24. Luna-Tortós C., Fedrowitz M., Löscher W. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology 2010, 58:1019-1032.
25. Ninomiya M., Ito K., Hiramatsu R., Horie T. Functional analysis of mouse and monkey multidrug resistance-associated protein 2 (Mrp2). Drug Metab Dispos 2006, 34:2056-2063.
26. Patil K.M., Bodhankar S.L. Simultaneous determination of lamotrigine, phenobarbitone, carbamazepine and phenytoin in human serum by high-performance liquid chromatography. J Pharm Biomed Anal 2005, 39:181-186.
27. Perucca E., Gram L., Avanzini G., Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998, 39:5-17.
28. Potschka H., Fedrowitz M., Löscher W. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR-rats. Epilepsia 2003, 44:1479-1486.
29. Potschka H., Fedrowitz M., Löscher W. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity. J Pharmacol Exp Ther 2003, 306:124-131.
30. Potschka H., Löscher W. Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain. Neuroreport 2001, 12:2387-2389.
31. Regesta G., Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res 1999, 34:109-122.
32. Schmidt D., Haenel F. Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine. Neurology 1984, 34:1252.
33. Sisodiya S.M., Lin W.R., Harding B.N., Squier M.V., Thom M. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 2002, 125:22-31.
34. Suzuki K., Omura S., Ohashi Y., Kawai M., Iwata Y., Tani K., Sekine Y., Takei N., Mori N. FK506 facilitates chemical kindling induced by pentylenetetrazole in rats. Epilepsy Res 2001, 46:279-282.
35. Tradtrantip L., Piyachaturawat P., Soroka C.J., Harry K., Mennone A., Mahagita C., Ballatori N., Boyer J.L. Phloracetophenone-induced choleresis in rats is mediated through Mrp2. Am J Physiol Gastrointest Liver Physiol 2007, 293:G66-G74.
36. Van Vliet E.A., Redeker S., Aronica E., Edelbroek P.M., Gorter J.A. Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats. Epilepsia 2005, 46:1569-1580.
37. Vogelgesang S., Kunert-Keil C., Cascorbi I., Mosyagin I., Schroder E., Runge U., Jedlitschky G., Kroemer H.K., Oertel J., Gaab M.R., Pahnke J., Walker L.C., Warzok R.W. Expression of multidrug transporters in dysembryoplastic neuroepithelial tumors causing intractable epilepsy. Clin Neuropathol 2004, 23:223-231.
38. Zhang C., Kwan P., Zuo Z., Baum L. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein. Life Sci 2010, 86:899-905.